POMONA RICERCA SRL has a total of 53 patent applications. Its first patent ever was published in 2003. It filed its patents most often in EPO (European Patent Office), China and Brazil. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are SHANGHAI NOVAMAB BIOPHARMACEUTICALS CO LTD, I MAB BIOPHARMA US LTD and AP BIOSCIENCES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 7 | |
#2 | China | 5 | |
#3 | Brazil | 4 | |
#4 | EAPO (Eurasian Patent Organization) | 4 | |
#5 | Republic of Korea | 4 | |
#6 | Mexico | 4 | |
#7 | United States | 4 | |
#8 | Australia | 3 | |
#9 | Canada | 3 | |
#10 | Israel | 2 | |
#11 | Italy | 2 | |
#12 | New Zealand | 2 | |
#13 | Singapore | 2 | |
#14 | WIPO (World Intellectual Property Organization) | 2 | |
#15 | South Africa | 2 | |
#16 | Hungary | 1 | |
#17 | Malaysia | 1 | |
#18 | Slovenia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Analysing materials | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Burioni Roberto | 47 |
#2 | Clementi Massimo | 46 |
#3 | Massimo Clementi | 4 |
#4 | Roberto Burioni | 3 |
#5 | Roberto Burionii | 1 |
Publication | Filing date | Title |
---|---|---|
CA2877598A1 | A human monoclonal antibody against the vp1 protein of jc virus | |
EP2552485A1 | Full-length immunoglobulins of the igg isotype capable of recognizing a heterosubtype neutralizing epitope on the hemagglutinin stem region and their use as anti-influenza medicament | |
EP2438088A1 | Monoclonal antibodies as a medicament for the therapeutic and/or prophylactic treatment of swine -origin influenza a (h1n1) virus (s-oiv) infections | |
NZ590115A | Monoclonal antibodies having homosubtype cross -neutralization properties against influenza a viruses subtype h1 | |
BRPI0909123A2 | MONOCLONAL ANTIBODIES, EXPRESSION VECTOR, HOST CELL, PHARMACEUTICAL COMPOSITION, USE OF THE REFERRED ANTIBODY, DIAGNOSTIC KIT AND TEST METHODS TO PARADECTECT THE PRESENCE OF INFLUENZA VIRUS EPITHES | |
EP2121763A2 | Anti-idiotype monoclonal antibodies as mimotopes of the hiv gp120 antigen | |
AU2003208000B2 | Human monoclonal antibody fab fragments directed against HCV E2 glycoprotein and endowed with in vitro neutralizing activity |